Norbert T. Sepp

Ordensklinikum Linz Elisabethinen
Linz, AT 
Ordensklinikum Linz Elisabethinen
Linz, AT 

Overview

Norbert Sepp practices practicing medicine in Linz, Austria.

His clinical expertise encompasses Lichen Sclerosus, Leukocyte Adhesion Deficiency Type 1, Systemic Sclerosis (SSc), Scleroderma, and Reconstructive Urology Surgery.

He is actively involved in clinical research, co-authoring 28 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Ordensklinikum Linz Elisabethinen
Linz, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

28 Total Publications

Oncofetal chondroitin sulfate positive circulating tumor cells as prognostic biomarkers in early-stage melanoma.
Oncofetal chondroitin sulfate positive circulating tumor cells as prognostic biomarkers in early-stage melanoma.
Journal: Scientific reports
Published: September 30, 2025

Frequently Asked Questions about Norbert T. Sepp

Is Norbert T. Sepp a top-rated expert for Lichen Sclerosus?

MediFind is an objective health platform that identifies experts based on real-world data. Norbert T. Sepp is classified as an Experienced expert for Lichen Sclerosus, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Norbert T. Sepp participate in research or clinical trials?

Yes. Norbert T. Sepp has published 28 articles and abstracts on conditions like Lichen Sclerosus. You can view a list of Norbert T. Sepp's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sepp's expertise for a condition
ConditionClose
        View All 14 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile